Literature DB >> 15202928

Penetration enhancement of transdermal delivery--current permutations and limitations.

Carryn H Purdon1, Chad G Azzi, Jin Zhang, Eric W Smith, Howard I Maibach.   

Abstract

In order to achieve enhanced topical drug delivery, it is necessary to make physical or biomolecular structural alterations to the stratum corneum by suitable techniques or by the use of specific chemical agents or drug carriers. The role of the chemical penetration enhancer is to reversibly alter the barrier properties of the stratum corneum by disruption of the membrane structures or by maximizing drug solubility within the skin. Alternatively, permeant delivery to the dermal vasculature using one of several physical methods to reduce diffusional resistance within the skin may be used to promote drug penetration. In the present article, we summarize the major facets of the diverse spectrum of penetration enhancement techniques that include modification of the stratum corneum, lipid-based delivery systems, drug/vehicle interactions, bypassing the stratum corneum, and electrical techniques of enhancement.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15202928     DOI: 10.1615/critrevtherdrugcarriersyst.v21.i2.20

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  13 in total

1.  Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2.

Authors:  Tomoko Hayashi; Michael Chan; John T Norton; Christina C N Wu; Shiyin Yao; Howard B Cottam; Rommel I Tawatao; Maripat Corr; Dennis A Carson; Gregory A Daniels
Journal:  Melanoma Res       Date:  2011-02       Impact factor: 3.599

2.  Intravesical Toll-like receptor 7 agonist R-837: optimization of its formulation in an orthotopic mouse model of bladder cancer.

Authors:  Tomoko Hayashi; Brian Crain; Maripat Corr; Michael Chan; Howard B Cottam; Roberto Maj; Alcide Barberis; Lorenzo Leoni; Dennis A Carson
Journal:  Int J Urol       Date:  2010-03-11       Impact factor: 3.369

3.  Investigation of effects of terpene skin penetration enhancers on stability and biological activity of lysozyme.

Authors:  Rahul M Varman; Somnath Singh
Journal:  AAPS PharmSciTech       Date:  2012-08-29       Impact factor: 3.246

4.  Effect of hydroxyl groups and rigid structure in 1,4-cyclohexanediol on percutaneous absorption of metronidazole.

Authors:  Yan Zhang; Fengping Tan; Weipu Jia; Nan Li; Jerry Zhang
Journal:  AAPS PharmSciTech       Date:  2014-05-13       Impact factor: 3.246

5.  Treatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune system.

Authors:  Tomoko Hayashi; Shiyin Yao; Brian Crain; Michael Chan; Rommel I Tawatao; Christine Gray; Linda Vuong; Fitzgerald Lao; Howard B Cottam; Dennis A Carson; Maripat Corr
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

6.  Ketotifen Fumarate and Salbutamol Sulphate Combined Transdermal Patch Formulations: In vitro release and Ex vivo Permeation Studies.

Authors:  M Yousuf; M Ahmad; M Usman; I Ali
Journal:  Indian J Pharm Sci       Date:  2013-09       Impact factor: 0.975

7.  Use of lipolanthionine peptide, a toll-like receptor 2 inhibitor, enhances transdermal delivery efficiency.

Authors:  Bin Chen; Da-Lie Liu; Wen-Yan Pan; Xiao-Hui Yang; Jia-Bao Shou; Ju-Hua Wu; Qing-Long Mao; Jia Wang
Journal:  Mol Med Rep       Date:  2014-05-20       Impact factor: 2.952

8.  Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates.

Authors:  Michael Chan; Tomoko Hayashi; Crystal S Kuy; Christine S Gray; Christina C N Wu; Maripat Corr; Wolfgang Wrasidlo; Howard B Cottam; Dennis A Carson
Journal:  Bioconjug Chem       Date:  2009-06       Impact factor: 4.774

9.  Safety evaluation of stamp type digital microneedle devices in hairless mice.

Authors:  Kui Young Park; Woo Sun Jang; Yun Young Lim; Joo Hee Ahn; Sang Jin Lee; Chan Woong Kim; Sung Eun Kim; Beom Joon Kim; Myeung Nam Kim
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

10.  Microneedle/nanoencapsulation-mediated transdermal delivery: mechanistic insights.

Authors:  Yasmine A Gomaa; Martin J Garland; Fiona J McInnes; Ryan F Donnelly; Labiba K El-Khordagui; Clive G Wilson
Journal:  Eur J Pharm Biopharm       Date:  2013-02-24       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.